These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 12092170)

  • 1. [Imidazoline receptors-normal and pathological factors].
    Nechifor M
    Rev Med Chir Soc Med Nat Iasi; 2001; 105(3):438-43. PubMed ID: 12092170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the receptor involved in the central hypotensive effect of rilmenidine and moxonidine.
    Bock C; Niederhoffer N; Szabo B
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):262-71. PubMed ID: 10344524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of I1 imidazoline receptors in the sympathoinhibition produced by intracisternally administered rilmenidine and moxonidine.
    Szabo B; Urban R
    Arzneimittelforschung; 1997 Sep; 47(9):1009-15. PubMed ID: 9342413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for imidazoline receptors involvement in the agmatine antidepressant-like effect in the forced swimming test.
    Zeidan MP; Zomkowski AD; Rosa AO; Rodrigues AL; Gabilan NH
    Eur J Pharmacol; 2007 Jun; 565(1-3):125-31. PubMed ID: 17445795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
    Boronat MA; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of locus coeruleus neurons by non-I1/I2-type imidazoline receptors: an in vivo and in vitro electrophysiological study.
    Ugedo L; Pineda J; Ruiz-Ortega JA; Martín-Ruiz R
    Br J Pharmacol; 1998 Dec; 125(8):1685-94. PubMed ID: 9886760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of noradrenaline release in pithed spontaneously hypertensive rats by I1-binding sites in addition to alpha2-adrenoceptors.
    Raasch W; Jungbluth B; Schäfer U; Häuser W; Dominiak P
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1063-71. PubMed ID: 12604683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imidazolines stimulate release of insulin from RIN-5AH cells independently from imidazoline I1 and I2 receptors.
    Olmos G; Kulkarni RN; Haque M; MacDermot J
    Eur J Pharmacol; 1994 Sep; 262(1-2):41-8. PubMed ID: 7813577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. I1-imidazoline receptors and cholinergic outflow to the airways.
    Haxhiu MA; Dreshaj IA; McFadden CB; Erokwu BO; Ernsberger P
    J Auton Nerv Syst; 1998 Jul; 71(2-3):167-74. PubMed ID: 9760053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moxonidine acting centrally inhibits airway reflex responses.
    Haxhiu MA; Dreshaj IA; McFadden CB; Erokwu BO; Ernsberger P
    Ann N Y Acad Sci; 1999 Jun; 881():372-82. PubMed ID: 10415940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of imidazolines and imidazoline receptors role at the vascular level.
    Serban DN; Nechifor M; Slătineanu SM
    Rev Med Chir Soc Med Nat Iasi; 2000; 104(4):37-44. PubMed ID: 12089957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacological analysis of the role of central alpha-2 adrenergic and imidazoline receptors in mechanism of the hypotensive effect of clonidine in rats].
    Kuz'min AI; Lodygin DN; Kalenikova EI; Bychkova EIu; Khokhlova ON; Murashev AN; Medvedev OS
    Eksp Klin Farmakol; 2000; 63(4):24-8. PubMed ID: 11022301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biphasic dose-dependent modulation of cardiac parasympathetic activity by moxonidine, an imidazoline I1-receptor agonist.
    Turcani M
    J Cardiovasc Pharmacol; 2008 Dec; 52(6):524-35. PubMed ID: 19034032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imidazoline receptor proteins are regulated in platelet-precursor MEG-01 cells by agonists and antagonists.
    Ivanov TR; Feng Y; Wang H; Regunathan S; Reis DJ; Chikkala DN; Gupta P; Jones JC; Piletz JE
    J Psychiatr Res; 1998; 32(2):65-79. PubMed ID: 9694002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central and renal I1 imidazoline preferring receptors: two unique sites mediating natriuresis in the rat.
    Penner SB; Smyth DD
    Cardiovasc Drugs Ther; 1994 Mar; 8 Suppl 1():43-8. PubMed ID: 7915136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The renaissance of centrally acting antihypertensive drugs.
    van Zwieten PA
    J Hypertens Suppl; 1999 Aug; 17(3):S15-21. PubMed ID: 10489094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moxonidine, a centrally acting antihypertensive agent, is a selective ligand for I1-imidazoline sites.
    Ernsberger P; Damon TH; Graff LM; Schäfer SG; Christen MO
    J Pharmacol Exp Ther; 1993 Jan; 264(1):172-82. PubMed ID: 8380858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that some imidazoline derivatives inhibit peripherally the vasopressor sympathetic outflow in pithed rats.
    Monroy-Ordoñez EB; Villalón CM; Cobos-Puc LE; Márquez-Conde JA; Sánchez-López A; Centurión D
    Auton Neurosci; 2008 Dec; 143(1-2):40-5. PubMed ID: 18774761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. alpha(2)-adrenergic receptors are not required for central anti-hypertensive action of moxonidine in mice.
    Tolentino-Silva FP; Haxhiu MA; Waldbaum S; Dreshaj IA; Ernsberger P
    Brain Res; 2000 Apr; 862(1-2):26-35. PubMed ID: 10799665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology and clinical use of moxonidine, a new centrally acting sympatholytic antihypertensive agent.
    Prichard BN; Owens CW; Graham BR
    J Hum Hypertens; 1997 Aug; 11 Suppl 1():S29-45. PubMed ID: 9321737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.